PTC Therapeutics, Inc.
PTCT
$50.41
-$0.16-0.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 629.17M | 594.84M | -363.30M | -453.20M | -479.52M |
| Total Depreciation and Amortization | 28.05M | 27.49M | 75.66M | 149.60M | 205.17M |
| Total Amortization of Deferred Charges | 1.21M | 1.20M | 1.20M | 1.19M | 1.46M |
| Total Other Non-Cash Items | 58.73M | 74.97M | 78.00M | 142.88M | 178.15M |
| Change in Net Operating Assets | -12.39M | -6.85M | 100.74M | -18.45M | -20.77M |
| Cash from Operations | 704.77M | 691.65M | -107.69M | -177.97M | -115.50M |
| Capital Expenditure | -7.33M | 1.36M | -6.50M | -8.30M | -14.14M |
| Sale of Property, Plant, and Equipment | 88.00K | 28.13M | 28.06M | 28.06M | 28.04M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -374.09M | -54.73M | 22.63M | -337.70M | -318.77M |
| Cash from Investing | -381.33M | -25.25M | 44.18M | -317.95M | -304.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -1.49M | -301.49M | -301.49M |
| Issuance of Common Stock | 46.76M | 47.49M | 33.76M | 9.71M | 12.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.54M | 217.25M | 223.59M | 1.14B | 1.16B |
| Cash from Financing | 22.22M | 264.74M | 255.87M | 849.88M | 870.87M |
| Foreign Exchange rate Adjustments | 18.87M | 95.00K | -7.33M | 4.42M | -6.45M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 364.53M | 931.24M | 185.03M | 358.38M | 444.05M |